Journal article
Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells
Oncogene, Vol.23(2), pp.368-378
01/15/2004
DOI: 10.1038/sj.onc.1207075
PMCID: PMC2854497
PMID: 14724565
Abstract
The neurofibromatosis type 1 tumor suppressor protein neurofibromin, is a GTPase activating protein for H-, N-, K-, R-Ras and TC21/R-Ras2 proteins. We demonstrate that Schwann cells derived from
Nf1
-null mice have enhanced chemokinetic and chemotactic migration in comparison to wild-type controls. Surprisingly, this migratory phenotype is not inhibited by a farnesyltransferase inhibitor or dominant-negative (dn) (N17)H-Ras (which inhibits H-, N-, and K-Ras activation). We postulated that increased activity of R-Ras and/or TC21/R-Ras2, due to loss of
Nf1
, contributes to increased migration. Mouse Schwann cells (MSCs) express R-Ras and TC21/R-Ras2 and their specific guanine exchange factors, C3G and AND-34. Infection of
Nf1
-null MSCs with a dn(43N)R-Ras adenovirus (to inhibit both R-Ras and TC21/R-Ras2 activation) decreases migration by approximately 50%. Conversely, expression of activated (72L)TC21/R-Ras2, but not activated (38V)R-Ras, increases migration, suggesting a role of TC21/R-Ras2 activation in the migration of neurofibromin-deficient Schwann cells. TC21/R-Ras2 preferentially couples to the phosphatidylinositol 3-kinase (PI3-kinase) and MAP kinase pathways. Treatment with a PI3-kinase or MAP kinase inhibitor reduces
Nf1
-null Schwann cell migration, implicating these TC21 effectors in Schwann cell migration. These data reveal a key role for neurofibromin regulation of TC21/R-Ras2 in Schwann cells, a cell type critical to NF1 tumor pathogenesis.
Details
- Title: Subtitle
- Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells
- Creators
- Yuan Huang - Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati, College of Medicine, 3125 Eden Ave., Cincinnati, OH 45267-0521, USAFatima Rangwala - Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati, College of Medicine, 3125 Eden Ave., Cincinnati, OH 45267-0521, USAPatricia C Fulkerson - Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati, College of Medicine, 3125 Eden Ave., Cincinnati, OH 45267-0521, USABo Ling - Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati, College of Medicine, 3125 Eden Ave., Cincinnati, OH 45267-0521, USAErin Reed - Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati, College of Medicine, 3125 Eden Ave., Cincinnati, OH 45267-0521, USAAdrienne D Cox - Departments of Radiation Oncology and Pharmacology, CB7512, Lineberger Cancer Center, UNC-CH, Chapel Hill, NC 27599, USAJohn Kamholz - Department of Neurology, Wayne State University, Elliman Building 3206, 421 East Canfield, Detroit, MI 48201, USANancy Ratner - Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati, College of Medicine, 3125 Eden Ave., Cincinnati, OH 45267-0521, USA
- Resource Type
- Journal article
- Publication Details
- Oncogene, Vol.23(2), pp.368-378
- DOI
- 10.1038/sj.onc.1207075
- PMID
- 14724565
- PMCID
- PMC2854497
- ISSN
- 0950-9232
- eISSN
- 1476-5594
- Language
- English
- Date published
- 01/15/2004
- Academic Unit
- Neurology; Psychiatry
- Record Identifier
- 9984020644002771
Metrics
12 Record Views